Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Robotics transforming cell therapy with 74% cost reduction
Biosyngen unveils TIL therapies strategies
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
Ryght AI and Biorasi to partner on AI
Mabwell ADC targeting CDH-17 gets IND clearance
Rett syndrome treatment ‘pivotal’
Sapient study revealing metabolic aging clock and disease insights
Zifo launches AI antibody engineering app to aid drug discovery